May Announcement: Opportunities for Institutions & Companies Developing Early-Stage Innovative Technologies in Cancer Care

NCI SBIR

May Announcement:
Opportunities for Institutions & Companies Developing
Early-Stage Innovative Technologies in Cancer Care

The deadlines for the following funding opportunities are rapidly approaching:

 

 

IMAT-SBIR 
May 29, 2014 – Applications Due

To view the full SBIR-IMAT FOA, please visit:
PAR-13-327, Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (R43/R44)

 
 
NIH Research Evaluation and Commercialization Hub (REACH) Awards (U01)
May 14, 2014 – Informational Webinar
May 26, 2014 – Letter of Intent Due 
June 26, 2014 – Application Due 

To view the full FOA, please visit:
RFA-OD-14-005, NIH Research Evaluation and Commercialization Hub (REACH) Awards (U01)

Or join the informational webinar to learn more: https://attendee.gotowebinar.com/register/6578187111589108993

The NIH Research Evaluation and Commercialization Hub (REACH) program will support proof-of-concept centers (Hubs) that facilitate and accelerate the translation of biomedical innovations into commercial products that improve patient care and enhance health.

The REACH Hubs will provide qualified institutions with the initial investment and resources to nurture innovators to develop high priority early-stage technologies within the NIH’s mission by providing: (1) infrastructure for identifying the most promising technologies, (2) funding for product definition studies (e.g., feasibility studies, prototype development, or proof-of-concept studies), (3) coordinated access to expertise in areas required for early stage technology development (including scientific, regulatory, reimbursement, business, legal, and project management), and (4) skills development and hands-on experience in entrepreneurism. Establishing public-private partnerships and providing additional non-federal funds will be critical for success.

 

 
Be sure to continue to check our website for updates and upcoming events. For a full list of funding opportunities currently available from the NCI SBIR & STTR Programs, please visit http://sbir.cancer.gov/funding/receipt_dates.asp.
The SBIR & STTR Programs are NCI’s engine of innovation for developing and commercializing novel technologies and products to prevent, diagnose, and treat cancer. The SBIR & STTR Programs are government set-aside programs for domestic small businesses to engage in research and development that has the potential for commercialization and public benefit.

Sign up to receive updates about
SBIR & STTR funding opportunities at
sbir.cancer.gov

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


%d bloggers like this: